Tender Title:

BOQBID

Reference Number:

d63a4f41

Issuing Authority:

The Department of Military Affairs under the Ministry of Defence is responsible for this tender.

Scope of Work and Objectives:

This tender involves the procurement of various pharmaceutical items which encompass a wide range of medications such as Ramipril 5mg, Ramipril 10mg, Silodosin 8mg, Sprionolactone 50mg, Frusemide 20mg, and others. The objective of this tender is to ensure timely and quality supply of essential medications required for military and defense personnel, contributing to their health and well-being.

The total quantity of medicines to be supplied is 18,264 units, which should be delivered in accordance with the specifications and requirements outlined in the bid documentation. The provision of these medications is critical to meet the health care standards for defense services.

Eligibility Criteria:

To qualify for participation in this tender, bidders must be registered entities with relevant licenses for pharmaceutical supply. This includes companies with a history of supplying medications to governmental or military institutions, ensuring that all products meet stringent health and safety standards.

Technical Requirements:

Bidders are required to adhere to specific technical specifications for each listed item. This includes, but is not limited to compliance with health regulations, the provision of product samples, and certifications guaranteeing the quality and safety of the medications provided.

Financial Requirements:

Potential bidders must demonstrate financial stability to undertake this project, including the ability to meet advance payments and provide performance guarantees if required. The details of the financial bid, including pricing and payment terms, must be submitted in accordance with the tender guidelines.

Document Submission Details:

All documents must be submitted electronically on the designated platform clearly delineated in the tender portal. The submission must include detailed technical and financial proposals, along with any requisite documentation or certificates verifying eligibility and qualifications.

Special Provisions:

This tender includes special provisions designed to support Micro, Small, and Medium Enterprises (MSEs) and startups. Such entities might have certain relaxations in terms of eligibility criteria or may benefit from reduced financial thresholds to encourage participation.

Evaluation Process:

Bids will undergo a rigorous evaluation process wherein both technical and financial proposals will be assessed. Preference may be given to proposals that demonstrate superior quality and compliance with the Make in India initiative, which encourages local sourcing and manufacturing.

Delivery Locations:

The medications will likely need to be delivered to designated military establishments, ensuring a swift and effective supply line directly to those in need.

Contact Information:

For inquiries relating to this tender, interested parties are encouraged to reach out through the tender platform or associated official channels as outlined in the tender guidelines.

This tender represents a significant opportunity for qualified suppliers of pharmaceuticals to contribute to the welfare and medical needs of defense personnel while complying with stringent quality and regulatory measures.